Literature DB >> 16497987

Role of endothelial nitric oxide synthase in the regulation of SREBP activation by oxidized phospholipids.

Nima M Gharavi1, Nancy A Baker, Kevin P Mouillesseaux, Winnie Yeung, Henry M Honda, Xavier Hsieh, Michael Yeh, Eric J Smart, Judith A Berliner.   

Abstract

Oxidized-1-palmitoyl-2-arachidonyl-sn-glycero-3-phosphorylcholine (Ox-PAPC), found in atherosclerotic lesions and other sites of chronic inflammation, activates endothelial cells (EC) to synthesize chemotactic factors, such as interleukin (IL)-8. Previously, we demonstrated that the sustained induction of IL-8 transcription by Ox-PAPC was mediated through the activation of sterol regulatory element-binding protein (SREBP). We now present evidence for the role of endothelial nitric oxide synthase (eNOS) in the activation of SREBP by Ox-PAPC. Ox-PAPC treatment of EC induced a dose- and time-dependent activation of eNOS, as measured by phosphorylation of serine 1177, dephosphorylation of threonine 495, and the conversion of L-arginine to L-citrulline. Activation of eNOS by Ox-PAPC was regulated through a phosphatidylinositol-3-kinase/Akt-mediated mechanism. These studies also demonstrated that pretreatment of EC with NOS inhibitor, Nomega-nitro-L-arginine-methyl ester (L-NAME), significantly inhibited Ox-PAPC-induced IL-8 synthesis. Because SREBP activation had been previously shown to regulate IL-8 transcription by Ox-PAPC, we examined the effects of L-NAME on Ox-PAPC-induced SREBP activation. Our data demonstrated that Ox-PAPC-induced SREBP activation and expression of SREBP target genes were significantly reduced by pretreatment with L-NAME. Interestingly, treatment of EC with NO donor, S-nitroso-N-acetylpenicillamine, did not activate SREBP, suggesting that NO alone was not sufficient for SREBP activation. Rather, our findings indicated that superoxide (O2*-), in combination with NO, regulated SREBP activation by Ox-PAPC. We found that Ox-PAPC treatment generated O2*- through an eNOS-mediated mechanism and that mercaptoethylguanidine, a peroxynitrite scavenger, reduced SREBP activation by Ox-PAPC. Taken together, these findings propose a novel role for eNOS in the activation of SREBP and SREBP-mediated inflammatory processes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16497987     DOI: 10.1161/01.RES.0000215343.89308.93

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  20 in total

1.  A role for NADPH oxidase 4 in the activation of vascular endothelial cells by oxidized phospholipids.

Authors:  Sangderk Lee; Nima M Gharavi; Henry Honda; Irene Chang; Brandon Kim; Nelson Jen; Rongsong Li; Alejandro Zimman; Judith A Berliner
Journal:  Free Radic Biol Med       Date:  2009-04-16       Impact factor: 7.376

2.  ABCA1 and ABCG1 protect against oxidative stress-induced macrophage apoptosis during efferocytosis.

Authors:  Laurent Yvan-Charvet; Tamara A Pagler; Tracie A Seimon; Edward Thorp; Carrie L Welch; Joseph L Witztum; Ira Tabas; Alan R Tall
Journal:  Circ Res       Date:  2010-04-29       Impact factor: 17.367

Review 3.  High-density lipoprotein: a novel target for antirestenosis therapy.

Authors:  Kai Yin; Devendra K Agrawal
Journal:  Clin Transl Sci       Date:  2014-07-15       Impact factor: 4.689

Review 4.  Role of phospholipid oxidation products in atherosclerosis.

Authors:  Sangderk Lee; Konstantin G Birukov; Casey E Romanoski; James R Springstead; Aldons J Lusis; Judith A Berliner
Journal:  Circ Res       Date:  2012-08-31       Impact factor: 17.367

5.  Substrate specificity and catalytic efficiency of aldo-keto reductases with phospholipid aldehydes.

Authors:  Matthew Spite; Shahid P Baba; Yonis Ahmed; Oleg A Barski; Kanchan Nijhawan; J Mark Petrash; Aruni Bhatnagar; Sanjay Srivastava
Journal:  Biochem J       Date:  2007-07-01       Impact factor: 3.857

Review 6.  Multiple indications for anti-inflammatory apolipoprotein mimetic peptides.

Authors:  Brian J Van Lenten; Mohamad Navab; G M Anantharamaiah; Georgette M Buga; Srinivasa T Reddy; Alan M Fogelman
Journal:  Curr Opin Investig Drugs       Date:  2008-11

7.  Anti-inflammatory apoA-I-mimetic peptides bind oxidized lipids with much higher affinity than human apoA-I.

Authors:  Brian J Van Lenten; Alan C Wagner; Chun-Ling Jung; Piotr Ruchala; Alan J Waring; Robert I Lehrer; Andrew D Watson; Susan Hama; Mohamad Navab; G M Anantharamaiah; Alan M Fogelman
Journal:  J Lipid Res       Date:  2008-07-11       Impact factor: 5.922

Review 8.  Structural identification and cardiovascular activities of oxidized phospholipids.

Authors:  Robert G Salomon
Journal:  Circ Res       Date:  2012-09-14       Impact factor: 17.367

Review 9.  Endothelial cell regulation by phospholipid oxidation products.

Authors:  Judith A Berliner; Nima M Gharavi
Journal:  Free Radic Biol Med       Date:  2008-04-20       Impact factor: 7.376

Review 10.  Generation and biological activities of oxidized phospholipids.

Authors:  Valery N Bochkov; Olga V Oskolkova; Konstantin G Birukov; Anna-Liisa Levonen; Christoph J Binder; Johannes Stöckl
Journal:  Antioxid Redox Signal       Date:  2010-04-15       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.